UK virtual fertility clinic Apricity raises €17m to expand geographically

The London-based virtual clinic Apricity has raised €17m to advance fertility care across Spain, Germany and Italy.
The funding round led by the Swiss healthtech investor MTIP, with participation from Iris Ventures, will also be used to expand Apricity’s at-home services, including ultrasound scans.
Apricity is the world’s first virtual fertility clinic and uses AI to increase the chances of conception.
The service assists patients on their fertility treatment journey and provides personalised support through its app.
The company’s tech team have developed AI algorithms that identify the most suitable fertility treatment for patients and then determine the best embryo for selection through 3D reconstruction.
“MTIP’s deep-rooted understanding of the healthcare landscape combined with Iris Ventures’ expertise in the consumer space will be invaluable as Apricity enters its next stage of growth and we expand into more regions,” said Caroline Noublanche, founder and CEO of Apricity.
“We look forward to supporting more women and couples across Europe who are struggling to conceive and can now hope for a better, less stressful alternative option.”
Christoph Kausch, managing partner at MTIP, said: “The virtual business model has really taken off across the healthcare industry, and Apricity was one of its pioneers.
“Rather than focusing on just one part of the fertility journey, Apricity is using cutting edge technology to transform the end-to-end experience for patients and has seen incredibly strong traction as a result.”
Marc Dietrich, who joins the board of directors on behalf of MTIP, added: “Fertility tech is one of the most important areas of healthcare innovation and we’re excited to support Apricity as it leads the industry to new heights.”
In May the clinic acquired Madrid-based period-tracking app Woom and signed up corporate customers as part of their employee benefits.
For more information, visit apricity.life.
Newsletter
Sign up for free weekly updates
The latest femtech news, research and investment, straight to your inbox.









